COMMUNIQUÉS West-GlobeNewswire

U.S. FDA Approves Portola Pharmaceuticals’ Andexxa®, First and Only Antidote for the Reversal of Factor Xa Inhibitors
04/05/2018
– Breakthrough Product is a Major Advance in the Treatment of Patients Hospitalized with Life-Threatening Bleeding – – Company to Host Conference Call on Friday, May 4, 2018 at 8:30 a.m. ET – SOUTH SAN FRANCISCO, Calif [...]
Teladoc Prices Upsized Offering of $250 Million of Convertible Senior Notes Due 2025
04/05/2018
PURCHASE, NY, May 03, 2018 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE: TDOC ) today announced the pricing of its offering of $250 million aggregate principal amount of Convertible Senior Notes due 2025 (the “Notes”) in a [...]
Compass Cannabis Terminates Proposed Transaction With Isodiol
04/05/2018
CALGARY, Alberta, May 03, 2018 (GLOBE NEWSWIRE) -- 10330698 Canada Ltd. (dba Compass Cannabis Clinic, or "the Company") has announced today that, pursuant to the terms of the binding letter agreement dated April 18, [...]
Radient Technologies Inc. Announces Closing of Real Estate Transactions
04/05/2018
EDMONTON, Alberta, May 03, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture:RTI) is pleased to announce it has completed its previously announced real estate acquisitions ( [...]
Terra Tech Corp. Schedules First Quarter 2018 Earnings Release for Thursday, May 10, 2018
03/05/2018
IRVINE, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp. (OTCQX:TRTC) (“Terra Tech” or the “Company”), a vertically integrated, cannabis-focused agriculture company, today announced that it will release its [...]
Tetraphase Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent Highlights
03/05/2018
WATERTOWN, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/05/2018
BURLINGTON, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced a grant of inducement stock options to seven new employees for an aggregate of 38,300 shares of common stock [...]
ReWalk Robotics Appoints Yohanan Engelhardt to its Board of Directors and as Chairman of the Audit Committee
03/05/2018
MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, May 03, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK ) (“ReWalk” or “the Company”) announced today that the Company has appointed Yohanan Engelhardt to the [...]
Adverum Biotechnologies Announces Leadership Changes
03/05/2018
MENLO PARK, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced that [...]
Emergent BioSolutions Reports First Quarter 2018 Financial Results
03/05/2018
Reaffirms full year 2018 financial forecast and operational goals Provides Q2 2018 revenue forecast of $205M-$230M GAITHERSBURG, Md., May 03, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS ) reported [...]
The Cooper Companies Announces Release Date for Second Quarter 2018
03/05/2018
PLEASANTON, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced it will release second quarter 2018 financial results on Thursday, June 7, 2018, at 4:15 PM ET. Following the [...]
LeMaitre Vascular to Present at Upcoming Investor Conferences
03/05/2018
BURLINGTON, Mass., May 03, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT ) announced today that it will be presenting in three conferences in May. David Roberts, President, is scheduled to present at [...]
Corvus Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
03/05/2018
BURLINGAME, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
TESARO Announces First-Quarter 2018 Operating Results
03/05/2018
ZEJULA Q1 net sales totaled $49 million Enrollment completed in Phase 3 PRIMA first-line ovarian cancer monotherapy trial TOPACIO platinum-resistant ovarian cancer and triple-negative breast cancer data accepted for [...]
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2018
03/05/2018
RANCHO CUCAMONGA, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) announced that the Company will release results for its first quarter of 2018 ended March 31, 2018, after the [...]
Adamas Reports First Quarter 2018 Financial Results
03/05/2018
GOCOVRI™ (amantadine) extended release capsules product sales hit $2.6 million for the first quarter of commercialization, with 1,608 fulfilled prescriptions Received positive feedback from the U.S. Food and Drug [...]
SeaSpine Reports First Quarter 2018 Financial Results
03/05/2018
Reiterates 2018 Financial Outlook CARLSBAD, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE ), a global medical technology company focused on surgical solutions for the treatment of [...]
Akcea Reports Financial Results and Highlights for First Quarter 2018
03/05/2018
TTR licensing transaction positions Akcea for two rare disease drug launches in 2018 FDA extended TEGSEDI TM (inotersen) PDUFA date to October 6, 2018 $445 million in pro forma cash to fund the company through key [...]
Fluidigm Announces First Quarter Financial Results and Operational Progress
03/05/2018
Product Innovations in Mass Cytometry and Genomics Total Revenue of $25.2 million, Genomics Revenue Growth of 18 Percent SOUTH SAN FRANCISCO, Calif., May 03, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM [...]

Pages